Expert Ratings for ShockWave Medical
Portfolio Pulse from Benzinga Insights
ShockWave Medical (NASDAQ:SWAV) has received various analyst ratings in the last quarter, with 1 bullish, 2 somewhat bullish, and 2 indifferent. The company's average 12-month price target is $289.4, a decrease of 5.58% from the previous average of $306.50.
September 29, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
ShockWave Medical has received mixed analyst ratings, with a decreased 12-month price target.
The mixed analyst ratings indicate uncertainty about the company's future performance. The decrease in the 12-month price target could potentially impact investor sentiment and the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100